Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Jerome Elliot Groopman, M.D.

TitleDina and Raphael Recanati Professor of Medicine
InstitutionBeth Israel Deaconess Medical Center
DepartmentMedicine
AddressBeth Israel Deaconess Medical Center
Department of Medicine
330 Brookline Ave
Boston MA 02215
Phone617/667-0070
Fax617/975-5244

 Mentoring 
 completed student projects
HIV-1 Tat Protein Mediated Endothelial Dysfunction in HIV Infection
Part Time/Continuation, 09/01/98 - 06/01/99
A Qualitative Study of the Pediatric-to-Adult Care Transition in Patients with Type I Diabetes
Summer, 04/02/12 - 08/15/12

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Prasad A, Shrivastava A, Papadopoulos E, Kuzontkoski PM, Reddy MV, Gillum AM, Kumar R, Reddy EP, Groopman JE. Combined administration of rituximab and on 013105 induces apoptosis in mantle cell lymphoma cells and reduces tumor burden in a mouse model of mantle cell lymphoma. Clin Cancer Res. 2013 Jan 1; 19(1):85-95.
    View in: PubMed
  2. Prasad A, Kuzontkoski PM, Shrivastava A, Zhu W, Li DY, Groopman JE. Slit2N/Robo1 Inhibit HIV-gp120-Induced Migration and Podosome Formation in Immature Dendritic Cells by Sequestering LSP1 and WASp. PLoS One. 2012; 7(10):e48854.
    View in: PubMed
  3. Nagaraja T, Chen L, Balasubramanian A, Groopman JE, Ghoshal K, Jacob ST, Leask A, Brigstock DR, Anand AR, Ganju RK. Activation of the Connective Tissue Growth Factor (CTGF)-Transforming Growth Factor ß 1 (TGF-ß 1) Axis in Hepatitis C Virus-Expressing Hepatocytes. PLoS One. 2012; 7(10):e46526.
    View in: PubMed
  4. Hartzband P, Groopman J. There is more to life than death. N Engl J Med. 2012 Sep 13; 367(11):987-9.
    View in: PubMed
  5. Maor Y, Yu J, Kuzontkoski PM, Dezube BJ, Zhang X, Groopman JE. Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium. Genes Cancer. 2012 Jul; 3(7-8):512-20.
    View in: PubMed
  6. Groopman JE. Much progress, still many challenges. AIDS. 2012 Jun 19; 26(10):1197.
    View in: PubMed
  7. Hartzband P, Groopman J. The new language of medicine. Obstet Gynecol. 2012 Feb; 119(2 Pt 1):369-70.
    View in: PubMed
  8. Zhang X, Yu J, Kuzontkoski PM, Zhu W, Li DY, Groopman JE. Slit2/Robo4 signaling modulates HIV-1 gp120-induced lymphatic hyperpermeability. PLoS Pathog. 2012 Jan; 8(1):e1002461.
    View in: PubMed
  9. Hartzband P, Groopman J. The new language of medicine. Minn Med. 2011 Dec; 94(12):36-7.
    View in: PubMed
  10. Hartzband P, Groopman J. The new language of medicine. N Engl J Med. 2011 Oct 13; 365(15):1372-3.
    View in: PubMed
  11. Shrivastava A, Kuzontkoski PM, Groopman JE, Prasad A. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Mol Cancer Ther. 2011 Jul; 10(7):1161-72.
    View in: PubMed
  12. Groopman J. The peanut puzzle: could the conventional wisdom on children and allergies be wrong? New Yorker. 2011 Feb; 26-30.
    View in: PubMed
  13. Preet A, Qamri Z, Nasser MW, Prasad A, Shilo K, Zou X, Groopman JE, Ganju RK. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Cancer Prev Res (Phila). 2011 Jan; 4(1):65-75.
    View in: PubMed
  14. Jiang S, Alberich-Jorda M, Zagozdzon R, Parmar K, Fu Y, Mauch P, Banu N, Makriyannis A, Tenen DG, Avraham S, Groopman JE, Avraham HK. Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. Blood. 2011 Jan 20; 117(3):827-38.
    View in: PubMed
  15. Jiang S, Zagozdzon R, Jorda MA, Parmar K, Fu Y, Williams JS, Wood JA, Makriyannis A, Banu N, Avraham S, Groopman JE, Avraham HK. Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment. J Biol Chem. 2010 Nov 12; 285(46):35471-8.
    View in: PubMed
  16. Zhang X, Maor Y, Wang JF, Kunos G, Groopman JE. Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator. Br J Pharmacol. 2010 Aug; 160(7):1583-94.
    View in: PubMed
  17. Groopman J. The plastic panic: how worried should we be about everyday chemicals? New Yorker. 2010 May; 26-31.
    View in: PubMed
  18. Hartzband P, Groopman J. Untangling the Web--patients, doctors, and the Internet. N Engl J Med. 2010 Mar 25; 362(12):1063-6.
    View in: PubMed
  19. Hartzband P, Groopman J. Keeping the patient in the equation--humanism and health care reform. N Engl J Med. 2009 Aug 6; 361(6):554-5.
    View in: PubMed
  20. Groopman J. Open channels: Do new cystic-fibrosis therapies hold the key to treating other genetic disorders? New Yorker. 2009 May 4; 30-4.
    View in: PubMed
  21. Groopman J, Hartzband P. Why 'quality' care is dangerous. Mo Med. 2009 May-Jun; 106(3):174-5.
    View in: PubMed
  22. Groopman J. That buzzing sound: the mystery of tinnitus. New Yorker. 2009 Feb 9; 42-9.
    View in: PubMed
  23. Prasad A, Park IW, Allen H, Zhang X, Reddy MV, Boominathan R, Reddy EP, Groopman JE. Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells. Oncogene. 2009 Mar 26; 28(12):1518-28.
    View in: PubMed
  24. Hartzband P, Groopman J. Other voices. Should money drive everything? Hosp Health Netw. 2009 Feb; 83(2):12.
    View in: PubMed
  25. Hartzband P, Groopman J. Money and the changing culture of medicine. N Engl J Med. 2009 Jan 8; 360(2):101-3.
    View in: PubMed
  26. Hartzband P, Groopman J. Off the record--avoiding the pitfalls of going electronic. N Engl J Med. 2008 Apr 17; 358(16):1656-8.
    View in: PubMed
  27. Groopman J. Buying a cure: what business know-how can do for disease. New Yorker. 2008 Jan 28; 38-43.
    View in: PubMed
  28. Balasubramanian A, Groopman JE, Ganju RK. Underlying pathophysiology of HCV infection in HIV-positive drug users. J Addict Dis. 2008; 27(2):75-82.
    View in: PubMed
  29. Groopman J. Crybabies: solving the colic conundrum. New Yorker. 2007 Sep 17; 46-54.
    View in: PubMed
  30. Zhang X, Wang JF, Kunos G, Groopman JE. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation. Cancer Res. 2007 Aug 1; 67(15):7230-7.
    View in: PubMed
  31. Preet A, Ganju RK, Groopman JE. Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene. 2008 Jan 10; 27(3):339-46.
    View in: PubMed
  32. Park IW, Reddy MV, Reddy EP, Groopman JE. Evaluation of novel cell cycle inhibitors in mantle cell lymphoma. Oncogene. 2007 Aug 16; 26(38):5635-42.
    View in: PubMed
  33. Groopman J. The right to a trial: Should dying patients have access to experimental drugs? New Yorker. 2006 Dec 18; 40-7.
    View in: PubMed
  34. Balasubramanian A, Ganju RK, Groopman JE. Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. J Infect Dis. 2006 Sep 1; 194(5):670-81.
    View in: PubMed
  35. Ghosh S, Preet A, Groopman JE, Ganju RK. Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes. Mol Immunol. 2006 Jul; 43(14):2169-79.
    View in: PubMed
  36. Balasubramanian A, Munshi N, Koziel MJ, Hu Z, Liang TJ, Groopman JE, Ganju RK. Structural proteins of Hepatitis C virus induce interleukin 8 production and apoptosis in human endothelial cells. J Gen Virol. 2005 Dec; 86(Pt 12):3291-301.
    View in: PubMed
  37. Balasubramanian A, Koziel M, Groopman JE, Ganju RK. Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV. Clin Infect Dis. 2005 Jul 1; 41 Suppl 1:S32-7.
    View in: PubMed
  38. Zhang X, Wang JF, Chandran B, Persaud K, Pytowski B, Fingeroth J, Groopman JE. Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection. J Biol Chem. 2005 Jul 15; 280(28):26216-24.
    View in: PubMed
  39. Groopman JE. A strategy for hope: a commentary on necessary collusion. J Clin Oncol. 2005 May 1; 23(13):3151-2.
    View in: PubMed
  40. Zhang X, Groopman JE, Wang JF. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. J Cell Physiol. 2005 Jan; 202(1):205-14.
    View in: PubMed
  41. Groopman J. A great case. N Engl J Med. 2004 Nov 11; 351(20):2043-5.
    View in: PubMed
  42. God at the bedside. N Engl J Med. 2004 Jul 8; 351(2):192-3; author reply 192-3.
    View in: PubMed
  43. Wang JF, Zhang X, Groopman JE. Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress. J Biol Chem. 2004 Jun 25; 279(26):27088-97.
    View in: PubMed
  44. Groopman J. God at the bedside. N Engl J Med. 2004 Mar 18; 350(12):1176-8.
    View in: PubMed
  45. Munshi N, Balasubramanian A, Koziel M, Ganju RK, Groopman JE. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis. 2003 Oct 15; 188(8):1192-204.
    View in: PubMed
  46. Balasubramanian A, Ganju RK, Groopman JE. Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J Biol Chem. 2003 Sep 12; 278(37):35755-66.
    View in: PubMed
  47. Choe EY, Schoenberger ES, Groopman JE, Park IW. HIV Nef inhibits T cell migration. J Biol Chem. 2002 Nov 29; 277(48):46079-84.
    View in: PubMed
  48. Tulpule A, Groopman J, Saville MW, Harrington W, Friedman-Kien A, Espina BM, Garces C, Mantelle L, Mettinger K, Scadden DT, Gill PS. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer. 2002 Jul 1; 95(1):147-54.
    View in: PubMed
  49. Miles SA, Dezube BJ, Lee JY, Krown SE, Fletcher MA, Saville MW, Kaplan L, Groopman J, Scadden DT, Cooley T, Von Roenn J, Friedman-Kien A. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma. AIDS. 2002 Feb 15; 16(3):421-9.
    View in: PubMed
  50. Schwarz KB, Kew M, Klein A, Abrams RA, Sitzmann J, Jones L, Sharma S, Britton RS, Di Bisceglie AM, Groopman J. Increased hepatic oxidative DNA damage in patients with hepatocellular carcinoma. Dig Dis Sci. 2001 Oct; 46(10):2173-8.
    View in: PubMed
  51. Wang JF, Zhang XF, Groopman JE. Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration. J Biol Chem. 2001 Nov 9; 276(45):41950-7.
    View in: PubMed
  52. Park IW, Ullrich CK, Schoenberger E, Ganju RK, Groopman JE. HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation. J Immunol. 2001 Sep 1; 167(5):2766-71.
    View in: PubMed
  53. Zhang XF, Wang JF, Matczak E, Proper JA, Groopman JE. Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Blood. 2001 Jun 1; 97(11):3342-8.
    View in: PubMed
  54. Yang YM, Hatch WC, Liu ZY, Du B, Groopman JE. Beta-chemokine induction of activation protein-1 and cyclic AMP responsive element activation in human myeloid cells. Cell Growth Differ. 2001 Apr; 12(4):211-21.
    View in: PubMed
  55. Park IW, Wang JF, Groopman JE. HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. Blood. 2001 Jan 15; 97(2):352-8.
    View in: PubMed
  56. Duvic M, Friedman-Kien AE, Looney DJ, Miles SA, Myskowski PL, Scadden DT, Von Roenn J, Galpin JE, Groopman J, Loewen G, Stevens V, Truglia JA, Yocum RC. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. Arch Dermatol. 2000 Dec; 136(12):1461-9.
    View in: PubMed
  57. Ullrich CK, Groopman JE, Ganju RK. HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. Blood. 2000 Aug 15; 96(4):1438-42.
    View in: PubMed
  58. Ganju RK, Brubaker SA, Chernock RD, Avraham S, Groopman JE. Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. J Biol Chem. 2000 Jun 9; 275(23):17263-8.
    View in: PubMed
  59. Wang JF, Park IW, Groopman JE. Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C. Blood. 2000 Apr 15; 95(8):2505-13.
    View in: PubMed
  60. Venkatakrishnan G, Salgia R, Groopman JE. Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem. 2000 Mar 10; 275(10):6868-75.
    View in: PubMed
  61. Groopman J. Medicine on Mars. New Yorker. 2000 Feb 14; 75(46):36-41.
    View in: PubMed
  62. Munshi N, Groopman JE, Gill PS, Ganju RK. c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells. J Immunol. 2000 Feb 1; 164(3):1169-74.
    View in: PubMed
  63. Munshi N, Ganju RK, Avraham S, Mesri EA, Groopman JE. Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor activation of c-jun amino-terminal kinase/stress-activated protein kinase and lyn kinase is mediated by related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2. J Biol Chem. 1999 Nov 5; 274(45):31863-7.
    View in: PubMed
  64. Park IW, Wang JF, Groopman JE. Expression and utilization of co-receptors in HIV and simian immunodeficiency virus infection of megakaryocytes. AIDS. 1999 Oct 22; 13(15):2023-32.
    View in: PubMed
  65. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst. 1999 Oct 6; 91(19):1616-34.
    View in: PubMed
  66. Park IW, Koziel H, Hatch W, Li X, Du B, Groopman JE. CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor. Am J Respir Cell Mol Biol. 1999 May; 20(5):864-71.
    View in: PubMed
  67. Dutt P, Wang JF, Groopman JE. Stromal cell-derived factor-1 alpha and stem cell factor/kit ligand share signaling pathways in hemopoietic progenitors: a potential mechanism for cooperative induction of chemotaxis. J Immunol. 1998 Oct 1; 161(7):3652-8.
    View in: PubMed
  68. Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, Newman W, Groopman JE. The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem. 1998 Sep 4; 273(36):23169-75.
    View in: PubMed
  69. Wang JF, Liu ZY, Groopman JE. The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood. 1998 Aug 1; 92(3):756-64.
    View in: PubMed
  70. Ganju RK, Munshi N, Nair BC, Liu ZY, Gill P, Groopman JE. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. J Virol. 1998 Jul; 72(7):6131-7.
    View in: PubMed
  71. Landrigan PJ, Carlson JE, Bearer CF, Cranmer JS, Bullard RD, Etzel RA, Groopman J, McLachlan JA, Perera FP, Reigart JR, Robison L, Schell L, Suk WA. Children's health and the environment: a new agenda for prevention research. Environ Health Perspect. 1998 Jun; 106 Suppl 3:787-94.
    View in: PubMed
  72. Hatch WC, Ganju RK, Hiregowdara D, Avraham S, Groopman JE. The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated and participates in colony-stimulating factor-1/macrophage colony-stimulating factor signaling in monocyte-macrophages. Blood. 1998 May 15; 91(10):3967-73.
    View in: PubMed
  73. Groopman JE. Fatigue in cancer and HIV/AIDS. Oncology (Williston Park). 1998 Mar; 12(3):335-44; discussion 345-6, 351.
    View in: PubMed
  74. Ganju RK, Dutt P, Wu L, Newman W, Avraham H, Avraham S, Groopman JE. Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. Blood. 1998 Feb 1; 91(3):791-7.
    View in: PubMed
  75. Wang JF, Ganju RK, Liu ZY, Avraham H, Avraham S, Groopman JE. Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor. Blood. 1997 Nov 1; 90(9):3507-15.
    View in: PubMed
  76. Liu ZY, Ganju RK, Wang JF, Schweitzer K, Weksler B, Avraham S, Groopman JE. Characterization of signal transduction pathways in human bone marrow endothelial cells. Blood. 1997 Sep 15; 90(6):2253-9.
    View in: PubMed
  77. Groopman JE. Impact of transfusion on viral load in human immunodeficiency virus infection. Semin Hematol. 1997 Jul; 34(3 Suppl 2):27-33.
    View in: PubMed
  78. Macé K, Aguilar F, Wang JS, Vautravers P, Gómez-Lechón M, Gonzalez FJ, Groopman J, Harris CC, Pfeifer AM. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis. 1997 Jul; 18(7):1291-7.
    View in: PubMed
  79. Hatch WC, Freedman AR, Boldt-Houle DM, Groopman JE, Terwilliger EF. Differential effects of interleukin-13 on cytomegalovirus and human immunodeficiency virus infection in human alveolar macrophages. Blood. 1997 May 1; 89(9):3443-50.
    View in: PubMed
  80. Inouye RT, Du B, Boldt-Houle D, Ferrante A, Park IW, Hammer SM, Duan L, Groopman JE, Pomerantz RJ, Terwilliger EF. Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector. J Virol. 1997 May; 71(5):4071-8.
    View in: PubMed
  81. Liu ZY, Ganju RK, Wang JF, Ona MA, Hatch WC, Zheng T, Avraham S, Gill P, Groopman JE. Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. J Clin Invest. 1997 Apr 1; 99(7):1798-804.
    View in: PubMed
  82. Ganju RK, Hatch WC, Avraham H, Ona MA, Druker B, Avraham S, Groopman JE. RAFTK, a novel member of the focal adhesion kinase family, is phosphorylated and associates with signaling molecules upon activation of mature T lymphocytes. J Exp Med. 1997 Mar 17; 185(6):1055-63.
    View in: PubMed
  83. Zrihan-Licht S, Lim J, Keydar I, Sliwkowski MX, Groopman JE, Avraham H. Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells. J Biol Chem. 1997 Jan 17; 272(3):1856-63.
    View in: PubMed
  84. Astier A, Avraham H, Manie SN, Groopman J, Canty T, Avraham S, Freedman AS. The related adhesion focal tyrosine kinase is tyrosine-phosphorylated after beta1-integrin stimulation in B cells and binds to p130cas. J Biol Chem. 1997 Jan 3; 272(1):228-32.
    View in: PubMed
  85. Chen J, Herceg-Harjacek L, Groopman JE, Grabarek J. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Blood. 1995 Dec 1; 86(11):4054-62.
    View in: PubMed
  86. Avraham S, London R, Fu Y, Ota S, Hiregowdara D, Li J, Jiang S, Pasztor LM, White RA, Groopman JE, et al. Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem. 1995 Nov 17; 270(46):27742-51.
    View in: PubMed
  87. Banu N, Wang JF, Deng B, Groopman JE, Avraham H. Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand. Blood. 1995 Aug 15; 86(4):1331-8.
    View in: PubMed
  88. Ellis MH, Avraham H, Groopman JE. The regulation of megakaryocytopoiesis. Blood Rev. 1995 Mar; 9(1):1-6.
    View in: PubMed
  89. Jiang S, Levine JD, Fu Y, Deng B, London R, Groopman JE, Avraham H. Cytokine production by primary bone marrow megakaryocytes. Blood. 1994 Dec 15; 84(12):4151-6.
    View in: PubMed
  90. Yamaguchi K, Groopman JE, Byrn RA. The regulation of HIV by retinoic acid correlates with cellular expression of the retinoic acid receptors. AIDS. 1994 Dec; 8(12):1675-82.
    View in: PubMed
  91. Roberts MR, Qin L, Zhang D, Smith DH, Tran AC, Dull TJ, Groopman JE, Capon DJ, Byrn RA, Finer MH. Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors. Blood. 1994 Nov 1; 84(9):2878-89.
    View in: PubMed
  92. Groopman JE. Thrombopoiesis. Capturing the unicorn. Curr Biol. 1994 Nov 1; 4(11):1016-8.
    View in: PubMed
  93. Grabarek J, Groopman JE, Lyles YR, Jiang S, Bennett L, Zsebo K, Avraham H. Human kit ligand (stem cell factor) modulates platelet activation in vitro. J Biol Chem. 1994 Aug 26; 269(34):21718-24.
    View in: PubMed
  94. Papp B, Zhang D, Groopman JE, Byrn RA. Stimulation of human immunodeficiency virus type 1 expression by ceramide. AIDS Res Hum Retroviruses. 1994 Jul; 10(7):775-80.
    View in: PubMed
  95. Avraham H, Banu N, Scadden DT, Abraham J, Groopman JE. Modulation of megakaryocytopoiesis by human basic fibroblast growth factor. Blood. 1994 Apr 15; 83(8):2126-32.
    View in: PubMed
  96. Scadden DT, Wang A, Zsebo KM, Groopman JE. In vitro effects of stem-cell factor or interleukin-3 on myelosuppression associated with AIDS. AIDS. 1994 Feb; 8(2):193-6.
    View in: PubMed
  97. Bennett BD, Cowley S, Jiang S, London R, Deng B, Grabarek J, Groopman JE, Goeddel DV, Avraham H. Identification and characterization of a novel tyrosine kinase from megakaryocytes. J Biol Chem. 1994 Jan 14; 269(2):1068-74.
    View in: PubMed
  98. Kunzi MS, Groopman JE. Identification of a novel human immunodeficiency virus strain cytopathic to megakaryocytic cells. Blood. 1993 Jun 15; 81(12):3336-42.
    View in: PubMed
  99. Avraham H, Cowley S, Chi SY, Jiang S, Groopman JE. Characterization of adhesive interactions between human endothelial cells and megakaryocytes. J Clin Invest. 1993 Jun; 91(6):2378-84.
    View in: PubMed
  100. Fischl MA, Krown SE, O'Boyle KP, Mitsuyasu R, Miles S, Wernz JC, Volberding PA, Kahn J, Groopman JE, Feinberg J, et al. Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group. J Acquir Immune Defic Syndr. 1993 Mar; 6(3):259-64.
    View in: PubMed
  101. Allan JD, Connolly KJ, Fitch H, Jackson-Pope L, McLaren C, Canetta R, Groopman JE. Long-term follow-up of didanosine administered orally twice daily to patients with advanced human immunodeficiency virus infection and hematologic intolerance of zidovudine. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S46-51.
    View in: PubMed
  102. Groopman JE. The use of growth hematopoietic factors in AIDS. Pathol Biol (Paris). 1992 Nov; 39(9):874-5.
    View in: PubMed
  103. Avraham H, Scadden DT, Chi S, Broudy VC, Zsebo KM, Groopman JE. Interaction of human bone marrow fibroblasts with megakaryocytes: role of the c-kit ligand. Blood. 1992 Oct 1; 80(7):1679-84.
    View in: PubMed
  104. Groopman JE, Molina JM. Nucleoside therapy for HIV infection--some answers, many questions. N Engl J Med. 1992 Aug 27; 327(9):639-41.
    View in: PubMed
  105. Groopman JE, Feder D. Hematopoietic growth factors in AIDS. Semin Oncol. 1992 Aug; 19(4):408-14.
    View in: PubMed
  106. Cowley SA, Groopman JE, Avraham H. Effects of transforming growth factor beta on megakaryocytic cell fusion and endomitosis. Int J Cell Cloning. 1992 Jul; 10(4):223-31.
    View in: PubMed
  107. Scadden DT, Wang Z, Groopman JE. Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction. J Infect Dis. 1992 Jun; 165(6):1119-23.
    View in: PubMed
  108. Avraham H, Vannier E, Chi SY, Dinarello CA, Groopman JE. Cytokine gene expression and synthesis by human megakaryocytic cells. Int J Cell Cloning. 1992 Mar; 10(2):70-9.
    View in: PubMed
  109. Avraham H, Vannier E, Cowley S, Jiang SX, Chi S, Dinarello CA, Zsebo KM, Groopman JE. Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood. 1992 Jan 15; 79(2):365-71.
    View in: PubMed
  110. Levine JD, Allan JD, Tessitore JH, Falcone N, Galasso F, Israel RJ, Groopman JE. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex. Blood. 1991 Dec 15; 78(12):3148-54.
    View in: PubMed
  111. Hodges TL, Kahn JO, Kaplan LD, Groopman JE, Volberding PA, Amman AJ, Arri CJ, Bouvier LM, Mordenti J, Izu AE, et al. Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complex. Antimicrob Agents Chemother. 1991 Dec; 35(12):2580-6.
    View in: PubMed
  112. Puisieux A, Lim S, Groopman J, Ozturk M. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res. 1991 Nov 15; 51(22):6185-9.
    View in: PubMed
  113. Connolly KJ, Allan JD, Fitch H, Jackson-Pope L, McLaren C, Canetta R, Groopman JE. Phase I study of 2'-3'-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine. Am J Med. 1991 Nov; 91(5):471-8.
    View in: PubMed
  114. Huberman M, Bering H, Fallon B, Tessitore J, Sonnenborn H, Paul S, Zeffren J, Levitt D, Groopman J. A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors. Cancer. 1991 Oct 15; 68(8):1708-13.
    View in: PubMed
  115. Molina JM, Ferriani R, Amirault C, Groopman JE. Purified recombinant CD4 inhibits HIV-1 infection of peripheral blood macrophages. Pathol Biol (Paris). 1991 Oct; 39(8):754-8.
    View in: PubMed
  116. Sakaguchi M, Zenzie-Gregory B, Groopman JE, Smale ST, Kim SY. Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery. J Virol. 1991 Oct; 65(10):5448-56.
    View in: PubMed
  117. Scadden DT, Feder D, Groopman JE. Scratching the surface. Curr Biol. 1991 Oct; 1(5):301-3.
    View in: PubMed
  118. Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. J Clin Oncol. 1991 May; 9(5):802-8.
    View in: PubMed
  119. Groopman JE. Treatment of AIDS with combinations of antiretroviral agents: a summary. Am J Med. 1991 Apr 10; 90(4A):27S-30S.
    View in: PubMed
  120. Groopman JE. Antiretroviral therapy and immunomodulators in patients with AIDS. Am J Med. 1991 Apr 10; 90(4A):18S-21S.
    View in: PubMed
  121. Groopman JE. The challenge of combination antiretroviral therapy for AIDS. An introduction. Am J Med. 1991 Apr 10; 90(4A):1S.
    View in: PubMed
  122. Groopman JE. AIDS. Of mice, monkeys and men. Nature. 1991 Feb 14; 349(6310):568-9.
    View in: PubMed
  123. Sakaguchi M, Sato T, Groopman JE. Human immunodeficiency virus infection of megakaryocytic cells. Blood. 1991 Feb 1; 77(3):481-5.
    View in: PubMed
  124. Evans LM, Itri LM, Campion M, Wyler-Plaut R, Krown SE, Groopman JE, Goldsweig H, Volberding PA, West SB, Mitsuyasu RT, et al. Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Immunother (1991). 1991 Feb; 10(1):39-50.
    View in: PubMed
  125. Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE. GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma. Am J Clin Oncol. 1991; 14 Suppl 1:S40-4.
    View in: PubMed
  126. Molina JM, Scadden DT, Sakaguchi M, Fuller B, Woon A, Groopman JE. Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood. 1990 Dec 15; 76(12):2476-82.
    View in: PubMed
  127. Sekigawa I, Chamow SM, Groopman JE, Byrn RA. CD4 immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type 2-infected lymphoid cells. J Virol. 1990 Oct; 64(10):5194-8.
    View in: PubMed
  128. Groopman JE. Management of the hematologic complications of human immunodeficiency virus infection. Rev Infect Dis. 1990 Sep-Oct; 12(5):931-7.
    View in: PubMed
  129. Groopman JE. Current advances in the diagnosis and treatment of AIDS: an introduction. Rev Infect Dis. 1990 Sep-Oct; 12(5):908-11.
    View in: PubMed
  130. Ikeuchi K, Kim S, Byrn RA, Goldring SR, Groopman JE. Infection of nonlymphoid cells by human immunodeficiency virus type 1 or type 2. J Virol. 1990 Sep; 64(9):4226-31.
    View in: PubMed
  131. Scadden DT, Zeira M, Woon A, Wang Z, Schieve L, Ikeuchi K, Lim B, Groopman JE. Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood. 1990 Jul 15; 76(2):317-22.
    View in: PubMed
  132. Groopman JE. Granulocyte-macrophage colony-stimulating factor in human immunodeficiency virus disease. Semin Hematol. 1990 Jul; 27(3 Suppl 3):8-14.
    View in: PubMed
  133. Groopman JE. Zidovudine intolerance. Rev Infect Dis. 1990 Jul-Aug; 12 Suppl 5:S500-6.
    View in: PubMed
  134. Molina JM, Scadden DT, Amirault C, Woon A, Vannier E, Dinarello CA, Groopman JE. Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells. J Virol. 1990 Jun; 64(6):2901-6.
    View in: PubMed
  135. Fischl M, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P, Miles S, Robbins W, Starrett B, Zalusky R, et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med. 1990 May 24; 322(21):1488-93.
    View in: PubMed
  136. Molina JM, Schindler R, Ferriani R, Sakaguchi M, Vannier E, Dinarello CA, Groopman JE. Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1). J Infect Dis. 1990 May; 161(5):888-93.
    View in: PubMed
  137. Zeira M, Byrn RA, Groopman JE. Inhibition of serum-enhanced HIV-1 infection of U937 monocytoid cells by recombinant soluble CD4 and anti-CD4 monoclonal antibody. AIDS Res Hum Retroviruses. 1990 May; 6(5):629-39.
    View in: PubMed
  138. Byrn RA, Mordenti J, Lucas C, Smith D, Marsters SA, Johnson JS, Cossum P, Chamow SM, Wurm FM, Gregory T, Groopman JE, Capon DJ. Biological properties of a CD4 immunoadhesin. Nature. 1990 Apr 12; 344(6267):667-70.
    View in: PubMed
  139. Molina JM, Sakaguchi M, Groopman JE. Effect of recombinant soluble CD4 on the in vitro growth of hematopoietic progenitor cells from AIDS patients. Blood. 1990 Mar 15; 75(6):1379-80.
    View in: PubMed
  140. Groopman JE. Status of colony-stimulating factors in cancer and AIDS. Semin Oncol. 1990 Feb; 17(1 Suppl 1):31-7; discussion 38-41.
    View in: PubMed
  141. Groopman JE. Retroviral infection and haemopoiesis. Ciba Found Symp. 1990; 148:173-80; discussion 180-5.
    View in: PubMed
  142. Heagy W, Groopman J, Schindler J, Finberg R. Use of IFN-gamma in patients with AIDS. J Acquir Immune Defic Syndr. 1990; 3(6):584-90.
    View in: PubMed
  143. Seage GR, Horsburgh CR, Hardy AM, Mayer KH, Barry MA, Groopman JE, Jaffe HW, Lamb GA. Increased suppressor T cells in probable transmitters of human immunodeficiency virus infection. Am J Public Health. 1989 Dec; 79(12):1638-42.
    View in: PubMed
  144. Molina JM, Groopman JE. Bone marrow toxicity of dideoxyinosine. N Engl J Med. 1989 Nov 23; 321(21):1478.
    View in: PubMed
  145. Groopman JE, Molina JM, Scadden DT. Hematopoietic growth factors. Biology and clinical applications. N Engl J Med. 1989 Nov 23; 321(21):1449-59.
    View in: PubMed
  146. Byrn RA, Sekigawa I, Chamow SM, Johnson JS, Gregory TJ, Capon DJ, Groopman JE. Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4. J Virol. 1989 Oct; 63(10):4370-5.
    View in: PubMed
  147. Scadden DT, Zon LI, Groopman JE. Pathophysiology and management of HIV-associated hematologic disorders. Blood. 1989 Oct; 74(5):1455-63.
    View in: PubMed
  148. Molina JM, Scadden DT, Byrn R, Dinarello CA, Groopman JE. Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus. J Clin Invest. 1989 Sep; 84(3):733-7.
    View in: PubMed
  149. Berman PW, Riddle L, Nakamura G, Haffar OK, Nunes WM, Skehel P, Byrn R, Groopman J, Matthews T, Gregory T. Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160. J Virol. 1989 Aug; 63(8):3489-98.
    View in: PubMed
  150. Groopman JE. New directions in hematologic biotherapy. Semin Hematol. 1989 Jul; 26(3 Suppl 3):1-6.
    View in: PubMed
  151. Gurley RJ, Ikeuchi K, Byrn RA, Anderson K, Groopman JE. CD4+ lymphocyte function with early human immunodeficiency virus infection. Proc Natl Acad Sci U S A. 1989 Mar; 86(6):1993-7.
    View in: PubMed
  152. Groopman JE, Scadden DT. Interferon therapy for Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS) Ann Intern Med. 1989 Mar 1; 110(5):335-7.
    View in: PubMed
  153. Ezekowitz RA, Kuhlman M, Groopman JE, Byrn RA. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med. 1989 Jan 1; 169(1):185-96.
    View in: PubMed
  154. Groopman JE. Clinical applications of colony-stimulating factors. Semin Oncol. 1988 Dec; 15(6 Suppl 6):27-33.
    View in: PubMed
  155. Johnson M, Caiazzo T, Molina JM, Donahue R, Groopman J. Inhibition of bone marrow myelopoiesis and erythropoiesis in vitro by anti-retroviral nucleoside derivatives. Br J Haematol. 1988 Oct; 70(2):137-41.
    View in: PubMed
  156. Zon LI, Groopman JE. Hematologic manifestations of the human immune deficiency virus (HIV). Semin Hematol. 1988 Jul; 25(3):208-18.
    View in: PubMed
  157. Groopman JE. Colony-stimulating factors: present status and future applications. Semin Hematol. 1988 Jul; 25(3 Suppl 3):30-7.
    View in: PubMed
  158. Berman PW, Groopman JE, Gregory T, Clapham PR, Weiss RA, Ferriani R, Riddle L, Shimasaki C, Lucas C, Lasky LA, et al. Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. Proc Natl Acad Sci U S A. 1988 Jul; 85(14):5200-4.
    View in: PubMed
  159. Groopman JE, Caiazzo T, Thomas MA, Ferriani RA, Saltzman S, Moon M, Seage G, Horsburgh CR, Mayer K. Lack of evidence of prolonged human immunodeficiency virus infection before antibody seroconversion. Blood. 1988 Jun; 71(6):1752-4.
    View in: PubMed
  160. O'Hara CJ, Groopman JE, Federman M. The ultrastructural and immunohistochemical demonstration of viral particles in lymph nodes from human immunodeficiency virus-related and non-human immunodeficiency virus-related lymphadenopathy syndromes. Hum Pathol. 1988 May; 19(5):545-9.
    View in: PubMed
  161. McCusker J, Stoddard AM, Mayer KH, Cowan DN, Groopman JE. Behavioral risk factors for HIV infection among homosexual men at a Boston community health center. Am J Public Health. 1988 Jan; 78(1):68-71.
    View in: PubMed
  162. Smith DH, Byrn RA, Marsters SA, Gregory T, Groopman JE, Capon DJ. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science. 1987 Dec 18; 238(4834):1704-7.
    View in: PubMed
  163. Benotti PN, Jenkins RL, Cady B, O'Hara C, Groopman JE. Surgical approach to generalized lymphadenopathy in homosexual men. J Surg Oncol. 1987 Dec; 36(4):231-4.
    View in: PubMed
  164. Cheson BD, Levine AM, Mildvan D, Kaplan LD, Wolfe P, Rios A, Groopman JE, Gill P, Volberding PA, Poiesz BJ, et al. Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group. JAMA. 1987 Sep 11; 258(10):1347-51.
    View in: PubMed
  165. Groopman JE, Mitsuyasu RT, DeLeo MJ, Oette DH, Golde DW. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med. 1987 Sep 3; 317(10):593-8.
    View in: PubMed
  166. Mayer KH, Falk LA, Paul DA, Dawson GJ, Stoddard AM, McCusker J, Saltzman SP, Moon MW, Ferriani R, Groopman JE. Correlation of enzyme-linked immunosorbent assays for serum human immunodeficiency virus antigen and antibodies to recombinant viral proteins with subsequent clinical outcomes in a cohort of asymptomatic homosexual men. Am J Med. 1987 Aug; 83(2):208-12.
    View in: PubMed
  167. Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23; 317(4):192-7.
    View in: PubMed
  168. Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23; 317(4):185-91.
    View in: PubMed
  169. Groopman JE. AIDS-related Kaposi's sarcoma: therapeutic modalities. Semin Hematol. 1987 Jul; 24(3 Suppl 2):5-8.
    View in: PubMed
  170. Groopman JE, Klein HG, Levine PH, Redfield RR, Sande MA. AIDS: questions and controversies--a panel discussion. Semin Hematol. 1987 Jul; 24(3 Suppl 2):9-19.
    View in: PubMed
  171. Donahue RE, Johnson MM, Zon LI, Clark SC, Groopman JE. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature. 1987 Mar 12-18; 326(6109):200-3.
    View in: PubMed
  172. Shaffer D, Pearl RH, Jenkins RL, Hammer SM, Dzik WJ, Groopman JE, Benotti PN, Monaco AP. HTLV-III/LAV infection in kidney and liver transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 3):2176-8.
    View in: PubMed
  173. Groopman JE. Biology and therapy of epidemic Kaposi's sarcoma. Cancer. 1987 Feb 1; 59(3 Suppl):633-7.
    View in: PubMed
  174. Groopman JE, Benz PM, Ferriani R, Mayer K, Allan JD, Weymouth LA. Characterization of serum neutralization response to the human immunodeficiency virus (HIV). AIDS Res Hum Retroviruses. 1987; 3(1):71-85.
    View in: PubMed
  175. Allan JS, Coligan JE, Lee TH, Barin F, Kanki PJ, M'Boup S, McLane MF, Groopman JE, Essex M. Immunogenic nature of a Pol gene product of HTLV-III/LAV. Blood. 1987 Jan; 69(1):331-3.
    View in: PubMed
  176. Marlink RG, Allan JS, McLane MF, Essex M, Anderson KC, Groopman JE. Low sensitivity of ELISA testing in early HIV infection. N Engl J Med. 1986 Dec 11; 315(24):1549.
    View in: PubMed
  177. Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood. 1986 Jul; 68(1):281-4.
    View in: PubMed
  178. Harris CC, LaVeck G, Groopman J, Wilson VL, Mann D. Measurement of aflatoxin B1, its metabolites, and DNA adducts by synchronous fluorescence spectrophotometry. Cancer Res. 1986 Jul; 46(7):3249-53.
    View in: PubMed
  179. Groopman JE. Therapy of epidemic Kaposi's sarcoma. Semin Hematol. 1986 Jul; 23(3 Suppl 1):14-9.
    View in: PubMed
  180. Groopman JE, Chen FW, Hope JA, Andrews JM, Swift RL, Benton CV, Sullivan JL, Volberding PA, Sites DP, Landesman S, et al. Serological characterization of HTLV-III infection in AIDS and related disorders. J Infect Dis. 1986 Apr; 153(4):736-42.
    View in: PubMed
  181. Groopman JE, Hammer SM, Sallan SE, Allan JD. Human T-lymphotropic virus type III infection in previously immunocompromised hosts. J Clin Oncol. 1986 Apr; 4(4):540-3.
    View in: PubMed
  182. Groopman JE, Sullivan JL, Mulder C, Ginsburg D, Orkin SH, O'Hara CJ, Falchuk K, Wong-Staal F, Gallo RC. Pathogenesis of B cell lymphoma in a patient with AIDS. Blood. 1986 Mar; 67(3):612-5.
    View in: PubMed
  183. Archibald DW, Zon L, Groopman JE, McLane MF, Essex M. Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS. Blood. 1986 Mar; 67(3):831-4.
    View in: PubMed
  184. Pennington JE, Groopman JE, Small GJ, Laubenstein L, Finberg R. Effect of intravenous recombinant gamma-interferon on the respiratory burst of blood monocytes from patients with AIDS. J Infect Dis. 1986 Mar; 153(3):609-12.
    View in: PubMed
  185. Resnick L, diMarzo-Veronese F, Schüpbach J, Tourtellotte WW, Ho DD, Müller F, Shapshak P, Vogt M, Groopman JE, Markham PD, et al. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med. 1985 Dec 12; 313(24):1498-504.
    View in: PubMed
  186. Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985 Dec 12; 313(24):1493-7.
    View in: PubMed
  187. Groopman JE. Clinical spectrum of HTLV-III in humans. Cancer Res. 1985 Sep; 45(9 Suppl):4649s-4651s.
    View in: PubMed
  188. Groopman JE, Hartzband PI, Shulman L, Salahuddin SZ, Sarngadharan MG, McLane MF, Essex M, Gallo R. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders. Blood. 1985 Sep; 66(3):742-4.
    View in: PubMed
  189. Sarna G, Mitsuyasu R, Figlin R, Ambersley J, Groopman J. Oral vinzolidine as therapy for Kaposi's sarcoma and carcinomas of lung, breast, and colon/rectum. Cancer Chemother Pharmacol. 1985; 14(1):12-4.
    View in: PubMed
  190. Groopman JE, Salahuddin SZ, Sarngadharan MG, Mullins JI, Sullivan JL, Mulder C, O'Hara CJ, Cheeseman SH, Haverkos H, Forgacs P, et al. Virologic studies in a case of transfusion-associated AIDS. N Engl J Med. 1984 Nov 29; 311(22):1419-22.
    View in: PubMed
  191. Groopman JE, Gottlieb MS, Goodman J, Mitsuyasu RT, Conant MA, Prince H, Fahey JL, Derezin M, Weinstein WM, Casavante C, et al. Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med. 1984 May; 100(5):671-6.
    View in: PubMed
  192. Mitsuyasu RT, Groopman JE. Biology and therapy of Kaposi's sarcoma. Semin Oncol. 1984 Mar; 11(1):53-9.
    View in: PubMed
  193. Mitsuyasu R, Groopman J, Volberding P. Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma. N Engl J Med. 1983 Jun 23; 308(25):1535-6.
    View in: PubMed
  194. Cochran AJ, Nestor MS, Groopman JE, Ahmed AR. Tumor infiltrates in acquired immunodeficiency syndrome patients with Kaposi's sarcoma. Lancet. 1983 Feb 19; 1(8321):416.
    View in: PubMed
  195. Groopman JE, Gottlieb MS. Kaposi's sarcoma: an oncologic looking glass. Nature. 1982 Sep 9; 299(5879):103-4.
    View in: PubMed
  196. Groopman JE, Soloff L, Tessler S. Hepatitis from isoniazid and rifampin. N Engl J Med. 1978 Jun 8; 298(23):1316-7.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Groopman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_